LUGARESI, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 8.074
NA - Nord America 7.307
AS - Asia 2.936
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 8
AF - Africa 5
OC - Oceania 5
Totale 18.356
Nazione #
US - Stati Uniti d'America 7.285
IT - Italia 1.958
UA - Ucraina 1.565
CN - Cina 1.547
IE - Irlanda 1.343
TR - Turchia 1.065
GB - Regno Unito 984
SE - Svezia 714
FR - Francia 629
DE - Germania 450
FI - Finlandia 320
IN - India 198
IR - Iran 37
VN - Vietnam 34
EU - Europa 21
RU - Federazione Russa 21
CA - Canada 19
BE - Belgio 18
JP - Giappone 18
IL - Israele 16
ES - Italia 10
GR - Grecia 10
PL - Polonia 10
DK - Danimarca 8
KR - Corea 8
AT - Austria 6
BR - Brasile 6
AU - Australia 5
MK - Macedonia 5
NL - Olanda 4
EG - Egitto 3
HR - Croazia 3
MX - Messico 3
RO - Romania 3
TW - Taiwan 3
BD - Bangladesh 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
LU - Lussemburgo 2
RS - Serbia 2
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
HK - Hong Kong 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MZ - Mozambico 1
NO - Norvegia 1
PH - Filippine 1
SG - Singapore 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 18.356
Città #
Jacksonville 1.788
Chandler 1.494
Dublin 1.332
Southend 798
Princeton 618
Izmir 600
Nanjing 462
Wilmington 349
Cambridge 303
Beijing 250
Ashburn 202
Altamura 200
Nanchang 182
Dearborn 157
Ann Arbor 150
Woodbridge 130
Boardman 97
Shenyang 93
Jiaxing 89
New York 84
Hebei 81
Milan 80
Chieti 75
Kunming 73
Rome 72
Tianjin 70
Norwalk 64
Houston 59
Grevenbroich 46
Hangzhou 45
Changsha 42
San Mateo 39
Torino 39
Dong Ket 33
Washington 33
Leawood 30
Ardabil 29
Bologna 28
Florence 27
Orange 26
Augusta 25
Jinan 24
Los Angeles 23
Helsinki 22
Naples 22
Changchun 20
Lanzhou 20
Bari 17
Guangzhou 16
Turin 16
Verona 16
Cedar Knolls 15
Monmouth Junction 15
Pisa 15
Campobasso 14
Ningbo 14
Brussels 13
Catanzaro 12
Genoa 12
Genova 12
Hanover 12
Seattle 12
Zhengzhou 12
Catania 11
Falls Church 11
Palermo 11
Taizhou 11
Auburn Hills 10
Casièr 9
Poggio Picenze 9
Tappahannock 9
Toronto 9
London 8
Venezia 8
Andover 7
Hefei 7
Massa E Cozzile 7
Mumbai 7
Napoli 7
Parma 7
Reggio Calabria 7
Teramo 7
Cagliari 6
Cazzago San Martino 6
Codogno 6
Montréal 6
Pescara 6
San Vito Chietino 6
Edinburgh 5
Perugia 5
Portici 5
Shanghai 5
Trieste 5
Viby J 5
Vicenza 5
Walnut 5
Brugherio 4
Dallas 4
Dolo 4
Düsseldorf 4
Totale 11.002
Nome #
La risposta simpatica cutanea: basi neurofisiologiche, valori normativi, applicazioni cliniche 1.187
Ruolo degli anticorpi anti-gangliosidi nelle neuropatie e nelle malattie del motoneurone 183
Un caso di mieloneuropatia da HTLV- I in Italia 177
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 173
Miastenia gravis "distale" e neuronopatia sensitiva simulanti una neuropatia sensori-motoria 165
Polineuropatia assonale cronica progressiva sensibile al trattamento steroideo: una neuropatia assonale primitiva o una variante della poliradicoloneuropatia cronica ingiammatoria demielinizzante? 156
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 130
IL 13 in multiple sclerosis 114
Anti-GD1a Antibodies from Acute Motor Axonal Neuropathy Patients Selectively Bind to Ranvier Nodes of Motor Nerve Fibers 111
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 99
Studio comparativo multicentrico sulla misurazione degli anticorpi IgM ANTI-GM1 nel siero di pazienti con neuropatia motoria multifocale e sclerosi laterale amiotrofica 98
Cleavage of cystatin C is not associated with multiple sclerosis 98
Utilità dell'ecobiometria del nervo ottico nella diagnosi e nel follow-up della neurite ottica retrobulbare 95
Utilità della tecnica destir (RM) nella diagnosi di neurite ottica retrobulbare 92
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 89
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 89
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients. 89
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 88
Transdermal scopolamine cycloplegia in juvenile diabetes 87
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 87
F response in vascular and degenerative upper motor neuron lesions 86
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 83
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 83
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 83
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 82
Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery 81
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 81
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 80
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei 80
Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier 80
Effect of TNF intraneural injection into the rat sciatic nerve 78
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 78
Adhesion molecule expression in sural nerve of chronic inflammatory demyelinating polineuropaty 78
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 78
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 78
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 78
Increasing age at disability milestones among MS patients in the MSBase Registry 76
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 75
Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant. 75
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 75
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 75
Hand dystonia due to cervical lesions 75
Anti-ganglioside antibodies in the Guillain-Barré syndrome (GBS): a case control study 74
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? 74
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 74
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 74
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 74
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 73
Chronic inflammatory demyelinating polyneuropathy in diabetes 73
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 73
May electrophysiology differentiate chronic inflammatory demyelinating polyneuropathy (CIDP) and polineuropathy with anti- SGPG antibodies? 73
Protein profiling of Guillain-Barrè Syndrome cerebrospinal fluid by two dimensional electrophoresis and mass spectrometry. 73
Binding of Anti GD1 a Antibodies in Peripheral Nerve. Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group - Chieti, March 26-27 1999 72
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 72
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 72
Anti-glicolipid antibodies in chronic inflammatory demyelinating polyneuropathy (CIDP) 71
Neurite ottica retrobulbare: studio biometrico del nervo ottico 71
Neurite ottica: relazione tra perimetria, PEV e RMN 71
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 71
Lack of vegetative and endocrine circadian rhythms in fatal familial thalamic degeneration 71
Patterns in patients’expression of emotions and neurologists’ response. 71
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 71
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 70
TheND1 gene of complex I is a mutational hot spot for Leber’s hereditary optic neuropathy 70
"Minimal" chronic inflammatory demyelinating polyneuropathy 68
Serum soluble adhesion molecules and proinflammatory cytokines are not increased in chronic inflammatory demyelinating polyneuropathy 68
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 68
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 68
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 68
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 68
Extrapyramidal syndrome and depression induced by flunarizine 68
Shared T Cell Receptor Usage of Cerebrospinal Fluid Cells in Familial Multiple Sclerosis da: X° National A.I.N.I. Congress Association Italiana Neuroimmunologia - Florence, Italy, November 15/16,1999 67
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 67
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 67
Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis 67
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 67
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 67
Aspetti immunologici delle poliradicoloneuriti croniche 66
Minimal and Ssymptomatic Chronic inflammatory demyelinating Polyneuropathy. da:Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group- Chieti Marzo 26-27-1999 66
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 66
76.Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy. 66
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 66
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 66
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis 65
Autoimmunity and interferon beta1B 65
Expression of adhesion molecules in sural nerve of chronic inflammatory demyelinating polyneuropathy (CIDP) 65
Chronic inflammatory demyelinating polyneuropathy in diabetes mellitus 65
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study 65
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 65
Interferon beta normalizes suppressor cell function in dysimmune neuropathies. 65
Demyelinating motor Guillain-Barré syndrome following Rubella 65
Livelli sierici e liquorali di IL13 nella Sclerosi Multipla 64
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 64
THE GP120 GLYCOPROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BINDS TO SENSORY GANGLION NEURONS 64
Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? 64
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 64
A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients. 64
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 64
Interferon beta1b: the Chieti experience 63
Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. 63
Totale 9.101
Categoria #
all - tutte 61.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019746 0 0 0 0 0 0 0 0 0 0 0 746
2019/20203.521 1.223 312 18 147 217 186 394 362 49 193 393 27
2020/20211.941 318 10 313 18 154 389 19 14 177 219 183 127
2021/20221.206 13 21 19 194 63 35 42 100 94 27 198 400
2022/20234.240 378 509 193 501 419 855 291 306 492 55 131 110
2023/20241.731 152 105 112 52 85 549 467 75 24 45 39 26
Totale 18.591